Institutional Ownership
Kiora Pharmaceuticals Inc
CUSIP 49721T507COMKPRXQ1 2026
13D / 13G Filings
13
Schedule 13D/13G on record
Beneficial Filers
9
Distinct reporting persons
Largest Stake
13.0%
Max % of class reported
Institutional Holders
14
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
13 filings · latest Jan 29, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jan 29, 2026 | Orin Hirschman | 13G/A | 4.9% | — | SEC |
| 2 | Nov 14, 2025 | Nantahala Capital Management, LLC | 13G/A | 10.0% | 363.7K | SEC |
| 3 | Aug 14, 2025 | Adar1 Capital Management, LLC | 13G/A | 13.0% | 365.2K | SEC |
| 4 | Aug 14, 2025 | Nantahala Capital Partners Limited Partnership | 13G | 5.3% | 189.7K | SEC |
| 5 | Feb 14, 2025 | Alyeska Investment Group, L.P. | 13G/A | 2.5% | 75.6K | SEC |
| 6 | Feb 12, 2025 | The Goldman Sachs Group, Inc. | 13G/A | 11.0% | 130 | SEC |
| 7 | Feb 10, 2025 | Orin Hirschman | 13G/A | 8.5% | 255.56B | SEC |
| 8 | Nov 14, 2024 | Alyeska Investment Group, L.P. | 13G | 8.4% | 256.4K | SEC |
| 9 | Nov 14, 2024 | Nantahala Capital Management, LLC | 13G | 10.0% | 306.3K | SEC |
| 10 | Nov 14, 2024 | Adar1 Capital Management, LLC | 13G | 10.0% | 310.8K | SEC |
3 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Kiora Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Adar1 Capital Management, LLC | 167.9K | $324.1K |
| 2 | Citadel Advisors LLC | 49.5K | $95.6K |
| 3 | Geode Capital Management, LLC | 47.9K | $92.3K |
| 4 | Xtx Topco Ltd | 14.7K | $28.4K |
| 5 | Two Sigma Securities, LLC | 12.0K | $23.2K |
| 6 | Rangeley Capital, LLC | 10.0K | $19.3K |
| 7 | Morgan Stanley | 1.4K | $2.7K |
| 8 | Ubs Group AG | 1.3K | $2.5K |
| 9 | Tower Research Capital LLC (Trc) | 995 | $1.9K |
| 10 | Sbi Securities Co., Ltd. | 256 | $494 |